Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: A parallel randomized trial

Annals of Internal Medicine

Volumn 157, Issue 12, 2012, Pages 846-855

  Kimball, Alexa B ^a   Kerdel, Francisco ^b   Adams, David ^c   Mrowietz, Ulrich ^d   Gelfand, Joel M ^e   Gniadecki, Robert ^f   Prens, Errol P ^g   Schlessinger, Joel ^h   Zouboulis, Christos C ⁱ   van der Zee, Hessel H ^h   Rosenfeld, Marie ^j   Mulani, Parvez ^j   Gu, Yihua ^j   Paulson, Susan ^j   Okun, Martin ^j   Jemec, Gregor B E ^k  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Florida Academic Dermatology Centers   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BISPEBJERG HOSPITAL   (Denmark)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h Aesthetica Day Spa   (United States)

ⁱ DESSAU MEDICAL CENTER   (Germany)

^j ABBOTT LABORATORIES   (United States)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; PLACEBO; STEROID;

ABSCESS DRAINAGE; ADULT; ANEMIA; ANUS FISSURE; ARTHRALGIA; ARTHRITIS; ARTICLE; BACKACHE; BACTEREMIA; BACTERIAL INFECTION; CELLULITIS; COCCIDIOIDOMYCOSIS; COLITIS; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DIARRHEA; DISEASE ACTIVITY; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ESCHERICHIA COLI INFECTION; FATIGUE; FEMALE; FOLLICULITIS; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; GENITAL TRACT INFECTION; GOITER; HEADACHE; HIDRADENITIS; HUMAN; HYPESTHESIA; INCISION; INFLUENZA; INTERSTITIAL LUNG DISEASE; LARYNX TUMOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NONCARDIAC CHEST PAIN; OROPHARYNX PAIN; OUTCOME ASSESSMENT; PAIN; PARALLEL DESIGN; PARESTHESIA; PENILE SWELLING; PHASE 2 CLINICAL TRIAL; PHYSICIAN GLOBAL ASSESSMENT; PILONIDAL SINUS; PRIORITY JOURNAL; PRURITUS; PUS; PUSTULAR PSORIASIS; PUSTULAR RASH; RANDOMIZED CONTROLLED TRIAL; RASH; RHINOPHARYNGITIS; SCORING SYSTEM; SCROTAL SWELLING; SINUSITIS; SUPPURATIVE HIDRADENITIS; TREATMENT RESPONSE; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VOMITING;

EID: 84871353413     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-12-201212180-00004     Document Type: Article

References (29)

1. Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91:328-32. [PMID: 21394419].
2. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971-4. [PMID: 9843011].
3. Jemec GB. Hidradenitis suppurativa. J Cutan Med Surg. 2003;7:47-56. [PMID: 12457209].
4. Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008; 17:455-6. [PMID: 18400064].
5. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596-601. [PMID: 18674845].
6. Zouboulis CC. Disorders of the apocrine sweat glands. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, eds. Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill; 2010.
7. Konig A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198:261-4. [PMID: 10393449].
8. Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161:831-9. [PMID: 19438453].
9. The MacArthur Initiative on Depression and Primary Care. Using PHQ-9 Diagnosis and Score for Initial Treatment Selection. Chicago, IL: John D. and Catherine T. MacArthur Foundation; 2012. Accessed at www.depression-primarycare.org/clinicians/toolkits/materials/forms/phq9/score_table on 22 February 2010.
10. Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90:264-8. [PMID: 20526543].
11. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144:809-13. [PMID: 11298541].
12. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J; Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007;56: 621-3. [PMID: 17097366].
13. Adams DR, Yankura JA, Fogelberg AC, Anderson BE. Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol. 2010;146:501-4. [PMID: 20479297].
14. Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22:325-8. [PMID: 6347922].
15. Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62:205-17. [PMID: 20115947].
16. Mortimer PS, Dawber RP, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115:263-8. [PMID: 2944534].
17. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60:539-61. [PMID: 19293006].
18. Plewig G. Acne and rosacea. In: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, eds. Braun-Falco's Dermatology. 3rd ed. Heidelberg, Germany: Springer-Verlag; 2009:1002-4.
19. Martinez F, Nos P, Benlloch S, Ponce J. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis. 2001;7:323-6. [PMID: 11720323].
20. Harde V, Mrowietz U. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab. J Dtsch Dermatol Ges. 2009;7:139-41. [PMID: 19371236].
21. Haslund P, Lee RA, Jemec GB. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol. 2009;89:595-600. [PMID: 19997689].
22. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-a, interleukin (IL)-1_ and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-a and IL-1_. Br J Dermatol. 2011;164:1292-8. [PMID: 21332464].
23. Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol. 2011;165:391-8. [PMID: 21457202].
24. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH, eds. Roenigk & Roenigk's Dermatologic Surgery. New York: Marcel Dekker; 1989:729.
25. National Research Council. The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: National Academies Pr; 2010.
26. Manton KG, Patrick CH, Johnson KW. Health differentials between blacks and whites: recent trends in mortality and morbidity. Milbank Q. 1987;65 Suppl 1:129-99. [PMID: 3327005].
27. Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes. 2006; 4:71. [PMID: 17005043].
28. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage. 2003;25:406-11. [PMID: 12727037].
29. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in healthrelated quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582-92. [PMID: 12719681].